The company will oversee the drug’s sale, marketing and distribution in the U.S. after acquiring the rights from Pragma Pharmaceuticals.
Tussionex has launched its generic of Tussionex, taking over marketing and distribution from Par Pharmaceuticals after Par's rights to the drug expire.
See the first comic in our Friday Pharmacy Phunny series in honor of American Pharmacists Month.
With the release of Congress’ Conference Report for the National Defense Authorization Acts come concerns over the bill’s impact on TRICARE beneficiaries.
Sanofi announced Thursday that it had launched its generic of Arava (lefluniomide) tablets through its U.S. generics division Winthrop.
Teva is acquring Rimsa, a pharmaceutical manufacturer and distributor based in one of the world's top emerging markets.
As the Center for Medicare and Medicaid services rolled out its plan for an Enhanced Medication Therapy Management model for pharmacies, KPMG’s Larry Kocot published a blog post for Health Affairs expanding on the announcement. “These changes are designed to better align the standalone prescription drug plan (“PDP”) sponsor and government financial interests, while also creating incentives for more robust investment and innovation in targeting medication therapy interventions,“ Kocot wrote. (Health Affairs)
NASP on Thursday announced that it had elected new leadership, established advisory committees for stakeholders and unveiled its new Center for Specialty Pharmacy Education.
The International Pharmacy Federation (FIP) has released two new reports that highlight both the changing role of pharmacy and the imperative for societies worldwide to recognize and compensate pharmacies adequately.
CVS Health continues to move toward digital health innovations, announcing two key partnerships that it hopes will foster the next batch of consumer-facing digital health solutions.